We are live on
!
Find out more
GIM
Glenmede Investment Management Portfolio holdings
AUM
$20.7B
This Fund
S&P 500
This Quarter
Est. Return
+9.24%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$19.8B
AUM Growth
–
Cap. Flow
+$18.6B
Cap. Flow
% of AUM
94.03%
Top 10 Holdings %
Top 10 Hldgs %
24.76%
Holding
1,498
New
1,498
Increased
–
Reduced
–
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard S&P 500 ETF
VOO
|
+$852M |
| 2 |
Microsoft
MSFT
|
+$699M |
| 3 |
Apple
AAPL
|
+$687M |
| 4 |
iShares Core S&P Small-Cap ETF
IJR
|
+$517M |
| 5 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$474M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.26% |
| 2 | Financials | 11.2% |
| 3 | Healthcare | 8.68% |
| 4 | Consumer Discretionary | 8.36% |
| 5 | Industrials | 6.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
851
Fabrinet
FN
$20.5B
| $606K | ﹤0.01% |
+2,056
| New | +$458K |
|
852
HEICO Corp
HEI
$52.1B
| $606K | ﹤0.01% |
+1,847
| New | +$511K |
|
|
MRUS
853
DELISTED
Merus
MRUS
| $606K | ﹤0.01% |
+11,517
| New | +$541K |
|
|
VRNA
854
DELISTED
Verona Pharma
VRNA
| $605K | ﹤0.01% |
+6,392
| New | +$473K |
|
855
Cboe Global Markets
CBOE
$30.4B
| $596K | ﹤0.01% |
+2,557
| New | +$569K |
|
856
Fresenius Medical Care
FMS
$12.6B
| $595K | ﹤0.01% |
+20,811
| New | +$558K |
|
857
Gentex
GNTX
$4.93B
| $594K | ﹤0.01% |
+27,015
| New | +$591K |
|
858
Teleflex
TFX
$6.03B
| $590K | ﹤0.01% |
+4,981
| New | +$628K |
|
859
FMC
FMC
$1.28B
| $585K | ﹤0.01% |
+14,013
| New | +$557K |
|
|
860
HEICO Corp Class A
HEI.A
$38B
| $582K | ﹤0.01% |
+2,250
| New | +$492K |
|
861
iShares Global 100 ETF
IOO
$9.43B
| $582K | ﹤0.01% |
+5,399
| New | +$536K |
|
862
Simply Good Foods
SMPL
$968M
| $582K | ﹤0.01% |
+18,414
| New | +$640K |
|
863
iShares Core MSCI Total International Stock ETF
IXUS
$60.7B
| $582K | ﹤0.01% |
+7,524
| New | +$549K |
|
864
Enphase Energy
ENPH
$5.39B
| $579K | ﹤0.01% |
+14,612
| New | +$675K |
|
865
Schwab U.S Small- Cap ETF
SCHA
$23.3B
| $578K | ﹤0.01% |
+22,854
| New | +$540K |
|
866
Brown-Forman Class B
BF.B
$12.8B
| $578K | ﹤0.01% |
+21,474
| New | +$689K |
|
867
SiteOne Landscape Supply
SITE
$4.22B
| $577K | ﹤0.01% |
+4,773
| New | +$564K |
|
868
KBR
KBR
$4.8B
| $576K | ﹤0.01% |
+12,010
| New | +$623K |
|
869
C.H. Robinson
CHRW
$17.1B
| $574K | ﹤0.01% |
+5,984
| New | +$561K |
|
870
Alexandria Real Estate Equities
ARE
$8.27B
| $571K | ﹤0.01% |
+7,863
| New | +$584K |
|
871
Fortis
FTS
$28.7B
| $567K | ﹤0.01% |
+11,878
| New | +$566K |
|
872
British American Tobacco
BTI
$120B
| $567K | ﹤0.01% |
+11,974
| New | +$530K |
|
873
Loews
L
$23.1B
| $565K | ﹤0.01% |
+6,164
| New | +$541K |
|
874
Essential Properties Realty Trust
EPRT
$6.62B
| $564K | ﹤0.01% |
+17,677
| New | +$565K |
|
875
John Wiley & Sons Class A
WLY
$2.53B
| $563K | ﹤0.01% |
+12,623
| New | +$532K |
|
Similar funds
CSS
ECM
JFL
BAM
SF
WIM
AIM
SIG
Glenmede Investment Management's Q2 2025 Portfolio in Review
Q2 2025 is the first quarter with a 13F filing on record for Glenmede Investment Management, which disclosed 1,498 positions worth $19.8B. Its ten largest holdings account for 25% of the portfolio.
Its largest position is Vanguard S&P 500 ETF: 1,621,868 shares worth $921M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, followed by Financials and Healthcare.
- Glenmede Investment Management's largest Q2 2025 buy was Vanguard S&P 500 ETF: 1,621,868 shares worth $921M.
- Glenmede Investment Management's ten largest holdings make up 25% of its $19.8B portfolio in Q2 2025.
- Glenmede Investment Management disclosed 1,498 positions in Q2 2025, its first 13F filing on record.
Based on Glenmede Investment Management's 13F filing for Q2 2025, filed 14 Aug 2025.